醫療應用軟體機器人市場機會、成長促進因素、產業趨勢分析及預測（2025-2034年）

2024 年全球醫療應用軟體機器人市場價值為 9,690 萬美元，預計到 2034 年將以 19.6% 的複合年成長率成長至 6.013 億美元。

市場成長主要得益於材料科學和機器人技術的快速發展。彈性體、水凝膠和形狀記憶聚合物等軟性材料的開發，使得製造能夠與人體安全互動的軟性生物相容性機器人設備成為可能。這些材料使機器人能夠適應人體輪廓，從而提高患者的舒適度並最大限度地降低受傷風險。當與先進感測器整合時，軟體機器人系統可以即時監測肌肉活動、壓力和關節運動，從而提高治療的精準度並實現個人化復健。這項技術革新正在拓展軟體機器人在醫療程序、穿戴式健康設備、復健工具和植入式系統的應用。遠距醫療、遠端監測和以患者為中心的護理模式的興起，進一步推動了軟體機器人技術在增強患者復健、活動能力和長期健康方面的應用。

穿戴式醫療設備因其在持續健康追蹤和遠距治療方面的應用而廣受歡迎。軟體機器人技術正在革新這一領域，提供更靈活、輕巧、舒適的穿戴式設備，可支持復健治療、輔助運動並改善睡眠品質。專為家庭使用而設計的設備，例如機器人手套和外骨骼，使行動不便或患有神經系統疾病的患者能夠獨立接受治療。與數位應用程式和雲端系統的整合確保了即時監測、資料共享和個人化治療方案的調整。隨著人們對患者獨立性和便利性的認知不斷提高，穿戴式軟體機器人解決方案正成為現代醫療保健系統的重要組成部分。

預計到2024年，外骨骼市佔率將達到63.5%。行動不便者人數的不斷增加，以及創傷和老年相關運動障礙病例的增多，正在推動這一領域的成長。軟體機器人外骨骼利用先進的感測器和執行器來模擬人體自然運動，幫助使用者恢復行走、站立和進行復健運動的能力。其靈活輕巧的結構使其適用於各種環境，包括醫院、家庭護理環境和復健中心。

到2024年，居家護理領域市佔率將達到49.3%。軟體機器人技術在居家復健的應用，透過提供便利且經濟實惠的照護方案，正在改變患者的復健方式。專為居家使用而設計的設備注重使用者舒適度和易用性，同時允許醫護人員進行遠端監督。此類技術有助於減少患者就醫次數，提升整體復健效果，使患者在熟悉的環境中獨立進行復健治療。

2024年，北美醫療軟體機器人市場佔據52.6%的市場佔有率，預計在整個預測期內將繼續保持領先地位。該地區的領先地位得益於其先進的醫療基礎設施、大量的研發投入以及對機器人和輔助技術的早期應用。不斷成長的老齡人口和日益普遍的慢性病正在推動對康復和輔助機器人系統的需求，進一步鞏固了區域市場的成長。

全球醫療應用軟體機器人市場的主要參與者包括BIOSERVO、HUNIC、MyoSwiss、OnRobot、Roceso Technologies、SYREBO、SIFSOF、Somnox和SRT。這些公司致力於產品創新、技術合作和臨床驗證，以鞏固其市場地位。許多公司投資開發生物相容性材料和整合感測器的系統，以提高醫療應用中的安全性、舒適性和適應性。與醫院、研究機構和復健中心建立策略合作夥伴關係，有助於擴大實際應用範圍並提高普及率。此外，各公司也優先考慮小型化和無線連接，以提升穿戴式裝置和居家護理設備的易用性。

目錄

第1章：方法論與範圍

第2章：執行概要

第3章：行業洞察

• 產業生態系分析
• 產業影響因素
  • 成長促進因素
    • 肌肉骨骼疾病發生率不斷上升
    • 軟材料和感測器技術的進步
    • 穿戴式醫療設備的日益普及
    • 對復健治療的需求不斷成長
  • 產業陷阱與挑戰
    • 設備成本高
    • 監管障礙和安全合規問題
  • 機會
    • 用於藥物傳輸和體內診斷
    • 為罕見疾病患者訂製義肢和輔助設備
• 成長潛力分析
• 監管環境
  • 北美洲
  • 歐洲
  • 亞太地區
• 技術與創新格局
  • 當前技術趨勢
  • 新興技術
• 投資環境
• 軟體機器人商業化面臨的挑戰
• 永續材料創新
• 未來路線圖與創新計劃
• 波特的分析
• PESTEL 分析
• 差距分析
• 未來市場趨勢

第4章：競爭格局

• 介紹
• 公司矩陣分析
• 公司市佔率分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 關鍵進展
  • 併購
  • 合作夥伴關係與合作
  • 新產品發布
  • 擴張計劃

第5章：市場估算與預測：依產品類型分類，2021-2034年

• 主要趨勢
• 外骨骼
• 軟握把

第6章：市場估算與預測：依類別分類，2021-2034年

• 主要趨勢
• 復健和輔助設備
• 揀選和放置

第7章：市場估計與預測：依應用領域分類，2021-2034年

• 主要趨勢
• 個人使用
• 工業用途

第8章：市場估算與預測：依最終用途分類，2021-2034年

• 主要趨勢
• 家庭護理機構
• 製藥和生物技術公司
• 其他最終用途

第9章：市場估計與預測：依地區分類，2021-2034年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• MEA
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第10章：公司簡介

• BIOSERVO
• HUNIC
• MyoSwiss
• OnRobot
• Roceso Technologies
• SYREBO
• SIFSOF
• somnox
• SRT

The Global Soft Robotics for Medical Applications Market was valued at USD 96.9 million in 2024 and is estimated to grow at a CAGR of 19.6% to reach USD 601.3 million by 2034.

The market growth is primarily driven by rapid advancements in materials science and robotics technology. The development of soft materials such as elastomers, hydrogels, and shape-memory polymers has enabled the creation of flexible and biocompatible robotic devices that can safely interact with the human body. These materials allow the robots to adapt to body contours, improving patient comfort and minimizing the risk of injury. When integrated with advanced sensors, soft robotic systems can monitor muscle activity, pressure, and joint movement in real time, enhancing precision in therapy and enabling personalized rehabilitation. This technological evolution is expanding the use of soft robotics in medical procedures, wearable health devices, rehabilitation tools, and implantable systems. The rise of telemedicine, remote monitoring, and patient-centered care is further promoting the use of soft robotic technologies to enhance recovery, mobility, and long-term well-being.

The wearable medical devices are gaining immense popularity for continuous health tracking and remote therapy. Soft robotics is revolutionizing this segment by delivering more adaptable, lightweight, and comfortable wearables that support rehabilitation, assist movement, and promote better sleep quality. Devices designed for home use, such as robotic gloves and exosuits, are enabling patients with limited mobility or neurological disorders to undergo therapy independently. Integration with digital applications and cloud-based systems ensures real-time monitoring, data sharing, and personalized treatment adjustments. With growing awareness around patient independence and convenience, wearable soft robotic solutions are becoming a vital part of modern healthcare systems.

The exoskeleton segment held a 63.5% share in 2024. The increasing number of individuals with mobility challenges, coupled with rising cases of trauma and age-related movement disorders, is fueling this segment's expansion. Soft robotic exoskeletons replicate the body's natural movements by using advanced sensors and actuators, helping users regain the ability to walk, stand, and perform rehabilitative exercises. Their flexible, lightweight structure makes them suitable for various settings, including hospitals, home care environments, and rehabilitation centers.

The home care settings segment held a 49.3% share in 2024. The adoption of soft robotics in home-based rehabilitation is transforming patient recovery by offering convenient and affordable care solutions. Devices designed for home use focus on user comfort and ease of operation while allowing remote supervision by healthcare providers. Such technologies help reduce hospital visits and enhance overall recovery outcomes, empowering patients to manage therapy independently in familiar surroundings.

North America Soft Robotics for Medical Applications Market held 52.6% share in 2024 and is projected to continue leading throughout the forecast period. The region's dominance is supported by its advanced healthcare infrastructure, significant investment in R&D, and early adoption of robotic and assistive technologies. A growing elderly population and the increasing prevalence of chronic conditions are driving demand for rehabilitation and assistive robotic systems, further strengthening regional market growth.

Prominent players in the Global Soft Robotics for Medical Applications Market include BIOSERVO, HUNIC, MyoSwiss, OnRobot, Roceso Technologies, SYREBO, SIFSOF, Somnox, and SRT. Companies in the Soft Robotics for Medical Applications Market are focusing on product innovation, technological collaboration, and clinical validation to strengthen their market position. Many are investing in the development of biocompatible materials and sensor-integrated systems that enhance safety, comfort, and adaptability in medical use. Strategic partnerships with hospitals, research institutions, and rehabilitation centers are helping expand real-world applications and adoption rates. Firms are also prioritizing miniaturization and wireless connectivity to improve usability in wearable and home care devices.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product type trends
  • 2.2.3 Category trends
  • 2.2.4 Application trends
  • 2.2.5 End use trends
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing incidences of musculoskeletal disorders
    • 3.2.1.2 Advancements in soft materials and sensor technologies
    • 3.2.1.3 Growing adoption of wearable medical devices
    • 3.2.1.4 Rising demand for rehabilitation therapies
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High device cost
    • 3.2.2.2 Regulatory hurdles and safety compliance issues
  • 3.2.3 Opportunities
    • 3.2.3.1 Use in drug delivery and internal diagnostics
    • 3.2.3.2 Custom prosthetics and assistive devices for rare conditions
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Investment landscape
• 3.7 Challenges in commercializing soft robotics
• 3.8 Sustainable material innovation
• 3.9 Future roadmap and innovation pipeline
• 3.10 Porter's analysis
• 3.11 PESTEL analysis
• 3.12 Gap analysis
• 3.13 Future market trends

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Exoskeleton
• 5.3 Soft grippers

Chapter 6 Market Estimates and Forecast, By Category, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Rehabilitation & assistive devices
• 6.3 Pick & place

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Personal use
• 7.3 Industrial use

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Homecare settings
• 8.3 Pharma and biotech companies
• 8.4 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 MEA
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 BIOSERVO
• 10.2 HUNIC
• 10.3 MyoSwiss
• 10.4 OnRobot
• 10.5 Roceso Technologies
• 10.6 SYREBO
• 10.7 SIFSOF
• 10.8 somnox
• 10.9 SRT